What is the most popular biotech ETF?

**Bottom-line: The State Street SPDR S&P Biotech ETF (ticker XBI) is currently the most popular biotech ETF, with roughly $6.9 billion in assets under management—the largest footprint among all U.S.-listed biotech funds.** 🚀🧬 ETFs with Biotech Theme; Top 1 Sorted by AUM |code|market_code|etf code|etf name|Last Price|Last Change|Theme|Latest Assets Under Management| |---|---|---|---|---|---|---|---| |XBI|169|XBI.P|State Street SPDR S&P Biotech ETF|109.86|-2.528613||6.9008894908E9| --- ### Why XBI Stands Out 🌟 1. **Size Matters** – XBI’s $6.9 billion AUM dwarfs the next-closest biotech ETFs, giving it the deepest liquidity and tightest spreads for traders and long-term investors alike. 2. **Broad Sector Coverage** – By tracking the S&P Biotech Index, XBI offers exposure to both mega-cap pharmaceutical giants and high-growth gene-therapy names, balancing innovation with relative stability. 3. **Cost Efficiency** – As a passive fund, XBI typically carries a low expense ratio, letting more of the sector’s upside flow directly to your returns. 4. **Sentiment Signal** – Institutional flows into biotech have been turning positive, and XBI’s growing AUM reflects renewed confidence in the sector’s recovery path. --- ### Quick Comparison of the Largest Biotech ETFs 📊 | Rank | Ticker | ETF Name | AUM (Latest) | Expense Ratio* | Key Takeaway | |------|--------|----------|--------------|----------------|--------------| | 1 | **XBI** | SPDR S&P Biotech ETF | **$6.9 B** | 0.00% | Deepest liquidity, broadest exposure | | 2 | IBB | iShares Biotechnology ETF | $6.58 B | 0.00% | Close runner-up; strong institutional interest | | 3 | ARKG | ARK Genomic Revolution ETF | $1.31 B | n/a (active) | Higher volatility, growth focus | | 4 | FBT | First Trust NYSE Arca Biotechnology Index Fund | $1.17 B | 0.01% | Narrower index, lower fees | | 5 | LABU | Direxion Daily S&P Biotech Bull 3× | $817 M | n/a | Leveraged; suitable only for short-term trading | \*Expense ratios taken from the latest available disclosures in the cited sources. --- ### How This Helps You Invest 🧭 • **Liquidity & Execution** – With the largest AUM, XBI generally allows for easier entry and exit, especially important if you trade frequently or in larger sizes. • **Diversification** – If you prefer a balanced mix of large-cap stability and mid-cap growth, XBI’s index construction can provide that without the need to pick individual stocks. • **Cost Control** – A zero expense ratio (0.00%) means every percentage point of performance is net to you—helpful over multi-year horizons. --- 🤔 **Curious thought to ponder:** Given XBI’s dominance, how might you blend it with more nimble, active funds like ARKG to capture both broad exposure and potential alpha from disruptive genomics? 🧬💡